StreetInsider.com News Articles

Form 4 SeaStar Medical Holding For: Aug 18 Filed by: Messinger Michael

Wed, 19 Aug 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260819/26950348.html

Form 4 SeaStar Medical Holding For: Aug 18 Filed by: Messinger Michael

Wed, 19 Aug 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260819/26950348.html

SeaStar Medical (ICU) Misses Q1 EPS by 4c

Wed, 12 Aug 2026 17:14:56 -0400

SeaStar Medical (NASDAQ: ICU) reported Q1 EPS of ($0.91), $0.04 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $60 thousand versus the consensus estimate of $486.5 thousand.

For earnings history and earnings-related data on SeaStar Medical (ICU) click here.

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its second quarter financial results after market close on Wednesday, August 12, 2026, and host a webcast and conference call to discuss its financial results and business progress.

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical sponsors pediatric AKI summit and plans webinar

Tue, 14 Jul 2026 08:34:35 -0400

SeaStar Medical Holding Corporation (Nasdaq: ICU) announced it is sponsoring the KidneyBee Summit 2026, held at Children's Hospital Colorado from July 14 to 16, 2026. The interdisciplinary conference brings together nurses, advanced practice providers, and physicians focused on pediatric acute kidney injury (AKI).

The company is also sponsoring an educational webinar titled Rethinking Pediatric Sepsis-Associated AKI: What Clinicians Should Know About QUELIMMUNE, scheduled for August 11, 2026, from 12:00 to 1:00 p.m. ET. Speakers include Dr. Stuart Goldstein of Cincinnati Children's Hospital Medical Center, Dr. Stephen Gorga and Katie Plomaritas of C.S. Mott Children's Hospital at the University of Michigan, Theresa

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)

Tue, 14 Jul 2026 08:34:00 -0400

Sponsors educational summit of leading pediatric AKI health care experts

Announces best practices webinar to further advance new treatment options

DENVER, July 14, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life announced today that it is a proud sponsor of key initiatives to advance the treatment of pediatric patients with acute kidney injury (AKI). AKI is a major driver of critical illness, prolonged hospital stays, and high